3rd Mitochondria-Related Drug Development

The 3rd Annual Mitochondria-Related Drug Development Summit returns for the first in-person meeting of 80+ industry experts to explore the unique opportunities of targeting mitochondrial dysfunction in rare and prevalent diseases. 

This September, unlock the breakthroughs in our understanding of mitochondrial biology, structure, and function, to accelerate drug development. Recent IND approvals and clinical successes prove the near-endless potential of mitochondria to treat cardiovascular, renal, and neurodegenerative diseases. 

Join us as we bring together rare mitochondrial disease experts and prevalent disease drug developers for a new era of targeting mitochondrial dysfunction.